Clinical Overestimation of HER2 Positivity in Early Estrogen and Progesterone Receptor-Positive Breast Cancer and the Value of Molecular Subtyping Using BluePrint.

J Glob Oncol · 2017 · PMC5560457 · PMID 28831439

Europe PMC DOI

hedged sentence

0.0002

closest p · 0.0× alpha

0.0002

boldest claim

The sentences

highly significantP = .0002actually significant

Interestingly, the difference in means of the HER2/CEP17 ratio was highly significant for MP high-risk versus low-risk tumors ( P = .0002; 95% CI for true difference in log-transformed means, 0.40 to 1.06).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.